Psychiatry and Neurology, Neurology · Evanston, IL
NPI
1366476715
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
800 Austin St Ste 363
Evanston, IL, 60202
Phone (847) 316-7055
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
904 services
Medicare patients, 2024
523
Average age 71
Drug cost, 2024
$2.0M
3,980 prescriptions
Company payments, 2025
$39K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Voci was code 99214 (office e&m - established), 594 times for 367 patients. In total James M Voci billed 904 services in 17 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 594 | 367 | $92.59 | $55K |
| 99204 Office E&M - New | Office | 184 | 184 | $124.83 | $23K |
| 95819 Neurologic | Facility | 38 | 38 | $42.92 | $1,631 |
| 96372 Injection Administration | Office | 24 | 15 | $10.69 | $257 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 24 | 15 | $0.89 | $21.47 |
By year: 2022 $56K for 630 services; 2023 $75K for 924 services; 2024 $81K for 904 services.
Medicare prescription drug claims, 2024
In 2024, the drug James M Voci prescribed most often to Medicare patients was Donepezil Hcl, with 570 prescriptions and refills. In total James M Voci wrote 3,980 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 570 | 1,152 | 162 | $4,968 |
| Epidiolex Cannabidiol (Cbd) | 340 | 356 | 31 | $938K |
| Memantine Hcl Generic | 253 | 439 | 61 | $4,442 |
| Levetiracetam Generic | 230 | 326 | 36 | $9,292 |
| Pregabalin Generic | 129 | 169 | 28 | $2,019 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 128 | 249 | 35 | $3,115 |
| Zonisamide Generic | 119 | 170 | 18 | $3,140 |
| Lacosamide Generic | 114 | 125 | 11 | $23K |
| Topiramate Generic | 112 | 180 | 25 | $923 |
| Gabapentin Generic | 109 | 192 | 34 | $2,092 |
| Divalproex Sodium Generic | 105 | 106 | 11 | $4,170 |
| Baclofen Generic | 89 | 158 | 32 | $1,357 |
| Amantadine Amantadine Hcl | 76 | 159 | 25 | $1,766 |
| Primidone Generic | 69 | 118 | 22 | $1,528 |
| Briviact Brivaracetam | 63 | 64 | Under 11 | $80K |
Brand drugs: 773 claims; generic drugs: 3,163 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Voci $39K ($39K in general payments such as food, travel and fees) from 25 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 30 | $21K |
| Jazz Pharmaceuticals Inc. JAZZ | 33 | $13K |
| Eisai Inc. 4523.T | 6 | $2,059 |
| Novartis Pharmaceuticals Corporation NVS | 22 | $342 |
| Lundbeck LLC | 25 | $317 |
| UCB, Inc. UCB.BR | 19 | $292 |
| Pfizer Inc. PFE | 17 | $284 |
| Teva Pharmaceuticals USA, Inc. TEVA | 14 | $279 |
| Abbvie Inc. ABBV | 6 | $128 |
| Biogen, Inc. BIIB | 5 | $99.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.